Key Takeaways
- • Healthpeak Properties and Brookfield Asset Management formed a $2.1 billion strategic joint venture involving an 86-property outpatient medical office portfolio across 11 U.S. states, with Healthpeak retaining 51% controlling interest and Brookfield acquiring 49%.
- • Healthpeak received approximately $1.025 billion in gross proceeds from the sale of Brookfield's 49% stake, implying a trailing cash capitalization rate of 5.9% and a per-square-foot valuation of $380, preserving balance sheet flexibility while maintaining operational control.
- • The portfolio comprises 5.6 million square feet with 95% occupancy and a weighted average remaining lease term of six years, diversified across Kentucky, Indiana, Pennsylvania, Arkansas, Illinois, Minnesota, New Jersey, and New York.
- • Healthpeak will serve as the managing member providing asset management, leasing, and property management services, with consolidated financial statement treatment while recognizing Brookfield's investment as non-controlling equity.
- • The structure includes a call right allowing Healthpeak to repurchase Brookfield's interest after year seven at a price providing Brookfield with a 6.5% net annual rate of return, balancing long-term capital access with future optionality.
Summary
Healthpeak Properties and Brookfield Asset Management have established a long-term strategic capital partnership structured as a joint venture centered on a high-performing U.S. outpatient medical office portfolio. Healthpeak contributed an 86-property portfolio valued at approximately $2.1 billion, comprising roughly 5.6 million square feet across 11 states including Kentucky, Indiana, Pennsylvania, Arkansas, Illinois, Minnesota, New Jersey, and New York. The portfolio demonstrates strong fundamentals with 95% lease occupancy and a weighted average remaining lease term of six years, positioning it as a stable income-generating asset base.
The transaction architecture preserves Healthpeak's operational control while providing substantial liquidity. Brookfield acquired a non-controlling 49% interest through an investment that generated approximately $1.025 billion in gross proceeds for Healthpeak, which retained the 51% controlling stake. The per-unit valuation implied by this transaction reaches approximately $380 per square foot, with a trailing cash capitalization rate of 5.9%. Healthpeak will continue as the managing member, responsible for asset management, leasing, and property management operations, while the joint venture will be consolidated on Healthpeak's financial statements with Brookfield's stake recorded as non-controlling equity interest.
The structure incorporates a call option providing Healthpeak with future flexibility. Beginning after year seven, Healthpeak may repurchase Brookfield's 49% interest at a price structured to deliver Brookfield a 6.5% net annual rate of return, excluding initial transaction expenses. This mechanism allows Healthpeak to regain full ownership if market conditions and financial positioning align with that objective, while Brookfield benefits from a defined return floor on its capital deployment. The partnership aligns Brookfield's long-term investment approach and scale with Healthpeak's sector expertise and operational platform, according to CEO Scott Brinker, positioning both parties to participate in the portfolio's future value creation while addressing Healthpeak's capital objectives.
The transaction architecture preserves Healthpeak's operational control while providing substantial liquidity. Brookfield acquired a non-controlling 49% interest through an investment that generated approximately $1.025 billion in gross proceeds for Healthpeak, which retained the 51% controlling stake. The per-unit valuation implied by this transaction reaches approximately $380 per square foot, with a trailing cash capitalization rate of 5.9%. Healthpeak will continue as the managing member, responsible for asset management, leasing, and property management operations, while the joint venture will be consolidated on Healthpeak's financial statements with Brookfield's stake recorded as non-controlling equity interest.
The structure incorporates a call option providing Healthpeak with future flexibility. Beginning after year seven, Healthpeak may repurchase Brookfield's 49% interest at a price structured to deliver Brookfield a 6.5% net annual rate of return, excluding initial transaction expenses. This mechanism allows Healthpeak to regain full ownership if market conditions and financial positioning align with that objective, while Brookfield benefits from a defined return floor on its capital deployment. The partnership aligns Brookfield's long-term investment approach and scale with Healthpeak's sector expertise and operational platform, according to CEO Scott Brinker, positioning both parties to participate in the portfolio's future value creation while addressing Healthpeak's capital objectives.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.